Philadelphia, PA USA

Our News on Newswise

Macrophages May Play Critical Role in Melanoma Resistance to BRAF Inhibitors


In the last several years, targeted therapies – drugs that directly impact specific genes and proteins involved in the progression of cancer – have been approved for a wide variety of cancers, including melanoma, the deadliest form of skin...
17-Mar-2015 11:00 AM EDT

Kerafast and The Wistar Institute Announce Collaboration through the Kerafast Fellows Program

Philadelphia-based biomedical research institute research The Wistar Institute and Boston-based life sciences company Kerafast, Inc. partner to offer educational opportunities for Wistar postdoctoral fellows and to distribute Wistar reagents through...
16-Mar-2015 3:05 PM EDT

Wistar Receives $1.1M Grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy to Establish a Consortium for Breast Cancer Research

The Jayne Koskinas Ted Giovanis (JKTG) Foundation awarded The Wistar Institute a $1.1 million grant to create The Jayne Koskinas Ted Giovanis Breast Cancer Research Consortium at The Wistar Institute. The Consortium will support the highly...
11-Mar-2015 10:00 AM EDT

New Therapeutic Strategy Discovered for Ovarian Cancer


Researchers in the laboratory of Rugang Zhang have discovered a target for ovarian clear cell carcinoma, a very difficult-to-treat form of the disease.
16-Feb-2015 3:00 PM EST

Bypassing Resistance to PI3K Therapy Paves the Way to Novel Anticancer Strategies


A study led by researchers at The Wistar Institute has shown that targeting both PI3K and the mitochondria within these cancer cells can dramatically improve the effectiveness of targeted therapy and significantly reduce the chances of developing...
12-Feb-2015 4:00 PM EST

Inflammation Application: How Tumor-Causing Cells are Recruited in Cancers Linked to Chronic Inflammatory Diseases


Gabrilovich and fellow investigators demonstrated what is happening at a cellular level that allows for chronic inflammation to cause a variety of cancers.
9-Feb-2015 4:00 PM EST

Wistar’s Kazuko Nishikura Receives $300K Grant from Macula Vision Research Foundation for Research into Degenerative Eye Disease


Kazuko Nishikura, Ph.D., receives Macula Vision Research Foundation grant for groundbreaking research to find new treatments for macular degeneration.
3-Feb-2015 10:10 AM EST

The Wistar Institute Welcomes Dustin Shilling and Completes its Technology Development and Commercialization Team


Wistar’s newly-created team of technology development professionals are in place to connect scientists’ research with translational science opportunities to form partnerships that will accelerate groundbreaking discoveries in medicine.
28-Jan-2015 11:00 AM EST

Our YouTube Videos